2645-32-1
2645-32-1
Chemical Structure
PR-619
- CAS No.: 2645-32-1
- Formula:C7H5N5S2
- Molecular Weight:223.28
IUPAC Name: 3,5-dithiocyanatopyridine-2,6-diamine
InChIKey: ZXOBLNBVNROVLC-UHFFFAOYSA-N
SMILES: NC1=C(SC#N)C=C(SC#N)C(N)=N1
Biological Activity: PR-619 is a broad-range and reversible DUB inhibitor with EC50s of 3.93, 4.9, 6.86, 7.2, and 8.61 μM for USP4, USP8, USP7, USP2, and USP5, respectively. PR-619 induces ER Stress and ER-Stress related apoptosis[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PR-619 | 99.26% | PR-619 is a broad-range and reversible DUB inhibitor with EC50s of 3.93, 4.9, 6.86, 7.2, and 8.61 μM for USP4, USP8, USP7, USP2, and USP5, respectively. PR-619 induces ER Stress and ER-Stress related apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PR-619 (Standard) | ≥98% | PR-619 (Standard) is the analytical standard of PR-619 (HY-13814). This product is intended for research and analytical applications. PR-619 is a broad-range and reversible DUB inhibitor with EC50s of 3.93, 4.9, 6.86, 7.2, and 8.61 μM for USP4, USP8, USP7, USP2, and USP5, respectively. PR-619 induces ER Stress and ER-Stress related apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.64
HY-D10612,4,5,6-Tetraaminopyrimidine -
Similarity Score 0.63
HY-W007705R6-Chloropyrimidine-2,4-diamine (Standard) -
Similarity Score 0.63
HY-100954R2,4-Diamino-6-hydroxypyrimidine (Standard) -
Similarity Score 0.62
HY-12444Y15 -
Similarity Score 0.61
HY-Y01982,6-Diaminopyridine -
Similarity Score 0.61
HY-W003561DHFR-IN-3 -
Similarity Score 0.60
HY-W0136317H-Purine-2,6-diamine -
Similarity Score 0.60
HY-1031728-Aminoadenine -
Similarity Score 0.60
HY-Y1117RMelamine (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. Altun M, et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem Biol. 2011 Nov 23;18(11):1401-12. [Content Brief]
- [2]. Bertuccio CA, et al. Anterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independent. PLoS One. 2014 Mar 14;9(3):e92013. [Content Brief]
- [3]. Seiberlich V, et al. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases. Biochim Biophys Acta. 2012 Nov;1823(1 [Content Brief]
- [4]. Kuan-Lin Kuo, et al. The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study. Cells. 2019 Oct 17;8(10):1268. [Content Brief]
